Global Sodium Iodohippurate[131I] Injection Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Sodium Iodohippurate[131I] Injection Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Iodohippurate Sodium I 131 Injection is a sterile solution containing o-iodohippurate sodium in which a portion of the molecules contain radioactive iodine (131I) in the molecular structure. Sodium iodohippurate (131I) injection is a sterile solution of sodium 2-(2-[131I]iodobenzamido)acetate. It may contain a suitable buffer and a suitable antimicrobial preservative such as benzyl alcohol. Iodine-131 is a radioactive isotope of iodine and may be obtained by neutron irradiation of tellurium or by extraction from uranium fission products.
Sodium Iodohippurate[131I] Injection report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Sodium Iodohippurate[131I] Injection market is projected to reach US$ 91 million in 2029, increasing from US$ 52 million in 2022, with the CAGR of 7.6% during the period of 2024 to 2029. Demand from Urology and Andrology Hospital and General Hospital are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Sodium Iodohippurate[131I] Injection industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Sodium Iodohippurate[131I] Injection key manufacturers include Mallinckrodt, Chengdu Gaotong Isotope Co.,Ltd. and Hta Co., Ltd, etc. Mallinckrodt, Chengdu Gaotong Isotope Co.,Ltd., Hta Co., Ltd are top 3 players and held % sales share in total in 2022.
Sodium Iodohippurate[131I] Injection can be divided into 37 MBq, 111 MBq, 185 MBq and 370 MBq, etc. 37 MBq is the mainstream product in the market, accounting for % sales share globally in 2022.
Sodium Iodohippurate[131I] Injection is widely used in various fields, such as Urology and Andrology Hospital and General Hospital, etc. Urology and Andrology Hospital provides greatest supports to the Sodium Iodohippurate[131I] Injection industry development. In 2022, global % sales of Sodium Iodohippurate[131I] Injection went into Urology and Andrology Hospital filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Sodium Iodohippurate[131I] Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Mallinckrodt
Chengdu Gaotong Isotope Co.,Ltd.
Hta Co., Ltd
Segment by Type
37 MBq
111 MBq
185 MBq
370 MBq
Others
Urology and Andrology Hospital
General Hospital
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Sodium Iodohippurate[131I] Injection market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Sodium Iodohippurate[131I] Injection, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Sodium Iodohippurate[131I] Injection industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Sodium Iodohippurate[131I] Injection in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Sodium Iodohippurate[131I] Injection introduction, etc. Sodium Iodohippurate[131I] Injection Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Sodium Iodohippurate[131I] Injection market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Sodium Iodohippurate[131I] Injection report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Sodium Iodohippurate[131I] Injection market is projected to reach US$ 91 million in 2029, increasing from US$ 52 million in 2022, with the CAGR of 7.6% during the period of 2024 to 2029. Demand from Urology and Andrology Hospital and General Hospital are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Sodium Iodohippurate[131I] Injection industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Sodium Iodohippurate[131I] Injection key manufacturers include Mallinckrodt, Chengdu Gaotong Isotope Co.,Ltd. and Hta Co., Ltd, etc. Mallinckrodt, Chengdu Gaotong Isotope Co.,Ltd., Hta Co., Ltd are top 3 players and held % sales share in total in 2022.
Sodium Iodohippurate[131I] Injection can be divided into 37 MBq, 111 MBq, 185 MBq and 370 MBq, etc. 37 MBq is the mainstream product in the market, accounting for % sales share globally in 2022.
Sodium Iodohippurate[131I] Injection is widely used in various fields, such as Urology and Andrology Hospital and General Hospital, etc. Urology and Andrology Hospital provides greatest supports to the Sodium Iodohippurate[131I] Injection industry development. In 2022, global % sales of Sodium Iodohippurate[131I] Injection went into Urology and Andrology Hospital filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Sodium Iodohippurate[131I] Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Mallinckrodt
Chengdu Gaotong Isotope Co.,Ltd.
Hta Co., Ltd
Segment by Type
37 MBq
111 MBq
185 MBq
370 MBq
Others
Segment by Application
Urology and Andrology Hospital
General Hospital
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Sodium Iodohippurate[131I] Injection market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Sodium Iodohippurate[131I] Injection, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Sodium Iodohippurate[131I] Injection industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Sodium Iodohippurate[131I] Injection in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Sodium Iodohippurate[131I] Injection introduction, etc. Sodium Iodohippurate[131I] Injection Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Sodium Iodohippurate[131I] Injection market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices